http://web.archive.org/web/20140719050304id_/http://www.dailymail.co.uk/health/article-2565479/Twice-day-pill-signals-end-painful-multiple-sclerosis-jabs.html

by @entity0 new @entity2 drug @entity3 could be made available on the @entity4 a twice - daily tablet could soon be given to multiple sclerosis patients as an alternative to painful injections			1
the drug @entity3 has been licensed in @entity10 and could be available on the @entity4 , allowing @entity10 patients to join the 35,000 already using the drug in other parts of the world			1
one neurologist said : ‘ this is what @entity2 patients have been waiting for			1
’ @entity3 ( dimethyl fumarate ) has been shown to reduce the rate of @entity2 relapses by more than a half and delay disability progression by over 20 per cent in adults with the most common form of the disease – relapsing remitting ms. the drug is a modified version of a treatment that was originally used to treat the skin disease psoriasis			1
‘ nobody is sure exactly how it works , ’ explains @entity31 , consultant neurologist at the @entity32 in @entity33			2
‘ it ’s a new approach to treating ms which is believed to help cells in the body defend themselves against the damage caused by @entity2 ’ the cost of @entity3 is £ 17,900 a year , similar to existing prescribed treatments			1
it ’s administered as a tablet , taken twice a day with food			0
the @entity45 surveyed more than 1,000 people with relapsing remitting @entity2 in 2010 , and 95 per cent of them said they wanted an alternative to injectable therapies			1
@entity50 , chief executive of the @entity45 , says : ‘ the fact this drug is now licensed is very good news			2
‘ effective as injectable treatments may be , the reality is that regular injections are not an appealing prospect , and many people experience injection - site reactions , which can be unpleasant			0
‘ we ’re expecting @entity4 advisory bodies to announce their decision on whether the treatment should be freely available in the coming months			1
‘ this approval is crucial , because without that , access to this medicine will be severely limited and reserved only for the few who can persuade their local @entity4 to pay for it			2
’ old ways : the most common treatment for @entity2 at the moment is injections neurologists are hopeful that @entity3 will be approved as a first - line therapy			1
dr @entity31 adds : ‘ it ’s effective , safe and convenient			0
many of my patients struggle with injections and some have even refused to go on to treatment until they could get an oral tablet			0
they ’ve been waiting for this			0
’ @entity82 , 39 , a catering manager from @entity83 , @entity84 , was diagnosed with @entity2 in 2008 and took part in a trial for @entity3			1
she says : ‘ i felt relieved when i got my diagnosis as i ’d felt so stressed not knowing what was wrong with me			0
‘ i ’d done lots of research when my symptoms started and was worried what it might be			0
‘ since being on the drug i have had some relapses but i ’ve managed to carry on a normal life , work full - time and take part in sports			2
‘ i had some minimal side effects – stomach upsets – but taking a tablet is preferable to having injections			0
‘ it ’s convenient , especially when going on holiday or visiting friends			0
i can have a much more normal life with tablets than injections			0
’ she adds : ‘ i try to live my life to the full and feel passionately that @entity2 should n’t rule my life			2
’ about 100,000 people in the @entity10 have @entity2 , an incurable , progressive condition that involves nerve damage			1
three times as many women as men have @entity2 and the average age of onset is 32			2
some 60 people are newly diagnosed each week .			0

the pill has been shown to reduce the rate of @entity2 relapses by 50 per cent
@entity3 has been licensed in @entity10 and could be available on the @entity4

@entity3:Tecfidera
@entity2:MS
@entity33:Edinburgh
@entity0:Hilary Freeman
@entity50:Michelle Mitchell
@entity10:Britain
@entity4:NHS
@entity45:MS Society
@entity82:Tracy Beers
@entity83:Mortimer
@entity84:Berkshire
@entity32:Anne Rowling Regenerative Neurological Clinic
@entity31:Weller